These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38315284)

  • 1. OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination.
    Peng L; Wu T; Liu Y; Zhao D; He W; Yuan Y
    Cell Oncol (Dordr); 2024 Jun; 47(3):987-1004. PubMed ID: 38315284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis.
    Duan F; Wu H; Jia D; Wu W; Ren S; Wang L; Song S; Guo X; Liu F; Ruan Y; Gu J
    J Hepatol; 2018 Jun; 68(6):1191-1202. PubMed ID: 29454068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OTUB1's role in promoting OSCC development by stabilizing RACK1 involves cell proliferation, migration, invasion, and tumor-associated macrophage M1 polarization.
    Li Y; Li R; Qin H; He H; Li S
    Cell Signal; 2023 Oct; 110():110835. PubMed ID: 37532135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog.
    Cao J; Zhao M; Liu J; Zhang X; Pei Y; Wang J; Yang X; Shen B; Zhang J
    Theranostics; 2019; 9(3):811-828. PubMed ID: 30809310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GNA14's interaction with RACK1 inhibits hepatocellular carcinoma progression through reducing MAPK/JNK and PI3K/AKT signaling pathway.
    Xu C; Li YM; Sun B; Zhong FJ; Yang LY
    Carcinogenesis; 2021 Nov; 42(11):1357-1369. PubMed ID: 34657150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
    Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
    Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK.
    Zhou Q; Zhou Q; Liu Q; He Z; Yan Y; Lin J; Chen Z; He C; Mao K; Wang J; Zhou Z; Xiao Z; Zhang J
    Theranostics; 2020; 10(22):10345-10359. PubMed ID: 32929353
    [No Abstract]   [Full Text] [Related]  

  • 8. OTUB1 Targets CHK1 for Deubiquitination and Stabilization to Facilitate Lung Cancer Progression and Radioresistance.
    Wang J; Liu Y; Wu D; Tian C; Gao J; Yang Q; Hong X; Gu F; Zhang K; Hu Y; Xu S; Liu L; Zeng Y
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1222-1233. PubMed ID: 38266782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
    Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
    [No Abstract]   [Full Text] [Related]  

  • 10. The deubiquitinase OTUD3 stabilizes ACTN4 to drive growth and metastasis of hepatocellular carcinoma.
    Xie P; Chen Y; Zhang H; Zhou G; Chao Q; Wang J; Liu Y; Fang J; Xie J; Zhen J; Wang Z; Hao L; Huang D
    Aging (Albany NY); 2021 Aug; 13(15):19317-19338. PubMed ID: 34380780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma.
    Ruan Y; Sun L; Hao Y; Wang L; Xu J; Zhang W; Xie J; Guo L; Zhou L; Yun X; Zhu H; Shen A; Gu J
    J Clin Invest; 2012 Jul; 122(7):2554-66. PubMed ID: 22653060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1.
    Qiu Y; Huang D; Sheng Y; Huang J; Li N; Zhang S; Hong Z; Yin X; Yan J
    Exp Cell Res; 2021 Aug; 405(1):112646. PubMed ID: 34029571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
    Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
    Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
    Song W; Zhang J; Xia Q; Sun M
    Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
    [No Abstract]   [Full Text] [Related]  

  • 16. NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma.
    Li KS; Zhu XD; Liu HD; Zhang SZ; Li XL; Xiao N; Liu XF; Xu B; Lei M; Zhang YY; Shi WK; Cao MQ; Xu YF; Tang ZY; Sun HC
    Cell Death Dis; 2020 May; 11(5):335. PubMed ID: 32382041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
    Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
    Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
    Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
    Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
    Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
    Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.